Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Metastasis02:30

Metastasis

6.2K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.2K
Initiation of Translation02:33

Initiation of Translation

37.9K
Initiating translation is complex because it involves multiple molecules. Initiator tRNA, ribosomal subunits, and eukaryotic initiation factors (eIFs) are all required to assemble on the initiation codon of mRNA. This process consists of several steps that are mediated by different eIFs.
First, the initiator tRNA must be selected from the pool of elongator tRNAs by eukaryotic initiation factor 2 (eIF2). The initiator tRNA (Met-tRNAi) has conserved sequence elements including modified bases at...
37.9K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

5.7K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.7K
Leaky Scanning02:28

Leaky Scanning

5.5K
During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA.  Marilyn Kozak discovered that the sequence RCCAUGG (where R...
5.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ki-67 promotes circulating tumor cell intravasation and metastasis in breast cancer.

Cell reports·2026
Same author

Dual-positive CTCs in patients with advanced breast cancer show metastatic potential and prognostic value.

Science translational medicine·2026
Same author

Novel Cell Cycle Inhibitors Decrease Primary and Metastatic Breast Cancer Growth In Vivo.

Cancers·2026
Same author

StealTHY: An immunogen-free CRISPR platform to expose concealed metastasis regulators in immunocompetent models.

Cell·2025
Same author

A growing entourage for heterotypic circulating tumor cell clusters.

Trends in cancer·2025
Same author

Macrovascular tumor infiltration and circulating tumor cell cluster dynamics in patients with cancer approaching the end of life.

Nature medicine·2025

Related Experiment Video

Updated: Dec 15, 2025

Circulating Tumor Cell Lines: an Innovative Tool for Fundamental and Translational Research
07:47

Circulating Tumor Cell Lines: an Innovative Tool for Fundamental and Translational Research

Published on: December 25, 2021

4.5K

Circulating tumor cells: Ready for translation?

Zoi Diamantopoulou1, Francesc Castro-Giner1,2, Nicola Aceto1

  • 1Department of Biomedicine, Cancer Metastasis Laboratory, University of Basel and University Hospital Basel, Basel, Switzerland.

The Journal of Experimental Medicine
|July 10, 2020
PubMed
Summary

Circulating tumor cells (CTCs) drive cancer metastasis. Recent advances highlight their potential for clinical application, marking a shift towards practical use in cancer care.

More Related Videos

Adaptation of Semiautomated Circulating Tumor Cell CTC Assays for Clinical and Preclinical Research Applications
14:14

Adaptation of Semiautomated Circulating Tumor Cell CTC Assays for Clinical and Preclinical Research Applications

Published on: February 28, 2014

16.1K
A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy
09:56

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on: February 21, 2025

1.1K

Related Experiment Videos

Last Updated: Dec 15, 2025

Circulating Tumor Cell Lines: an Innovative Tool for Fundamental and Translational Research
07:47

Circulating Tumor Cell Lines: an Innovative Tool for Fundamental and Translational Research

Published on: December 25, 2021

4.5K
Adaptation of Semiautomated Circulating Tumor Cell CTC Assays for Clinical and Preclinical Research Applications
14:14

Adaptation of Semiautomated Circulating Tumor Cell CTC Assays for Clinical and Preclinical Research Applications

Published on: February 28, 2014

16.1K
A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy
09:56

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on: February 21, 2025

1.1K

Area of Science:

  • Oncology
  • Cancer Metastasis Research
  • Translational Cancer Science

Background:

  • Circulating tumor cells (CTCs) are key drivers of cancer metastasis.
  • Understanding CTC biology is crucial for developing new cancer therapies.
  • Current research focuses on the clinical relevance of CTC detection.

Purpose of the Study:

  • To review recent discoveries in circulating tumor cell (CTC) research.
  • To identify challenges and future trends in CTC investigations.
  • To advocate for the translation of CTC research into clinical practice.

Main Methods:

  • Literature review of recent CTC studies.
  • Analysis of current challenges in CTC detection and analysis.
  • Exploration of emerging technologies and methodologies for CTC research.

Main Results:

  • Significant progress has been made in understanding CTC heterogeneity and function.
  • Technological advancements have improved CTC isolation and characterization.
  • Clinical validation studies are essential for integrating CTCs into patient care.

Conclusions:

  • Circulating tumor cell research is rapidly evolving.
  • Overcoming current challenges will facilitate clinical translation.
  • CTCs hold significant promise for improving cancer diagnosis, prognosis, and treatment monitoring.